Immunic Therapeutics logo — Immunic is a biotechnology company developing small molecule...

Immunic Therapeutics

Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases

Founded 2016 United States United States 91 employees Post Ipo Equity Total: $520.00M Biotechnology, Health and Wellness +1

General Information

Company Name Immunic Therapeutics
Founded Year 2016
Location United States United States +2
Employees 91
Industries Biotechnology, Health and Wellness, Life Sciences
Funding Stage Post Ipo Equity
Social

Get notified when Immunic Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Immunic Therapeutics

Immunic Therapeutics is a biotechnology company founded in 2016 and headquartered in the United States. The company's focus lies in the development of small molecule therapies for chronic inflammatory and autoimmune diseases. Immunic, listed on Nasdaq under the ticker symbol IMUX, boasts a clinical pipeline of orally administered treatments designed to address these conditions. The latest significant milestone for Immunic was a $240.00MPost-IPO Equity investment, which took place on 04 January 2024. This round of investment saw participation from major players in the investment landscape, including Adage Capital Management, BVF Partners, Janus Handerson, RTW Investments, Soleus Capital, and Avidity Partners. Through this, Immunic has solidified its standing and financial backing, positioning itself for further growth and industry impact in the realm of biotechnology.

Immunic's slogan is: "Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases". The company's Privacy Policy can be found at: https://imux.com/privacy-policy/

Taxonomy: small molecule therapies, chronic inflammatory diseases, autoimmune diseases, clinical pipeline, oral administration, Nasdaq listed, drug development, precision medicine, pharmaceuticals, immunology, autoimmune disorders

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 6
Investor Investor Investor Investor Investor
•••• ••••
04 Jan 2024
Post-IPO Equity •••••• 10
Investor Investor Investor Investor Investor Investor Investor Investor
•••• ••••
10 Oct 2022
Post-IPO Equity •••••• - 15 Jul 2021
Post-IPO Equity •••••• - 04 Aug 2020
Post-IPO Equity •••••• - 09 Jun 2020

View All 10 Funding Rounds

Immunic Therapeutics Alternatives & Competitors

Immunic Therapeutics vs
OD-OS Inc
OD-OS Inc United States

Navilas® - the only navigated retina laser for non-contact focal and PRP treatment plus micro second...

43 employees
Biotechnology, Health Care
Immunic Therapeutics vs
enduco
enduco Germany

On a mission to be your most trusted partner for endurance training. 🚵🏼‍♀️ 🏃🏼‍♀️ 🏊🏾

Seed
9 employees
Health and Wellness, Sports
Immunic Therapeutics vs

Powering a low-carbon sustainable future.

47 employees
Finance, Financial Services

FAQ About Immunic Therapeutics

Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases
Immunic Therapeutics was founded in 2016.
Immunic Therapeutics is headquartered in United States.
Immunic Therapeutics operates in the following industries: Biotechnology, Health and Wellness, Life Sciences.
Immunic Therapeutics has approximately 91 employees.
Immunic Therapeutics has completed 10 funding rounds, raising a total of $520.00M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Immunic Therapeutics include OD-OS Inc, enduco, Sunco Capital, EOM Pharmaceuticals , CleverPush. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Immunic Therapeutics and OD-OS Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Immunic Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy